Back to Journals » Cancer Management and Research » Volume 2

Cancer Management and Research


Archive: Volume 2, 2010

Cancer chemotherapy: targeting folic acid synthesis

Nicole Hagner, Markus Joerger

Cancer Management and Research 2010, 2:293-301

Published Date: 19 November 2010

The disparity of health facilities in an urban area discourages proposed treatment application in inoperable lung cancer patients

Georgios Hillas, Petros Bakakos, Miltiadis Trichas, et al

Cancer Management and Research 2010, 2:287-291

Published Date: 15 November 2010

Review of catumaxomab in the treatment of malignant ascites

Martin Sebastian

Cancer Management and Research 2010, 2:283-286

Published Date: 8 November 2010

The potential carcinogenic risk of tanning beds: clinical guidelines and patient safety advice

Mette Mogensen, Gregor BE Jemec

Cancer Management and Research 2010, 2:277-282

Published Date: 28 October 2010

FACE: the barefaced facts of AI potency

Alain Monnier

Cancer Management and Research 2010, 2:267-276

Published Date: 27 October 2010

Epigenomics in cancer management

Fabricio F Costa

Cancer Management and Research 2010, 2:255-265

Published Date: 27 October 2010

Radiotherapy combined with hormonal therapy in prostate cancer: the state of the art

Piotr Milecki, Piotr Martenka, Andrzej Antczak, et al

Cancer Management and Research 2010, 2:243-253

Published Date: 11 October 2010

New developments in treatment of ovarian carcinoma: focus on trabectedin

Philippe A Cassier, Aude Duret, Olivier Trédan, et al

Cancer Management and Research 2010, 2:233-242

Published Date: 1 October 2010

Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms

Joseph Tripodi, Ronald Hoffman, Vesna Najfeld, et al

Cancer Management and Research 2010, 2:219-223

Published Date: 17 September 2010

Treatment of cutaneous melanoma: current approaches and future prospects

Alain P Algazi, Christopher W Soon, Adil I Daud

Cancer Management and Research 2010, 2:197-211

Published Date: 17 August 2010

Efficacy and safety of amrubicin hydrochloride for treatment of relapsed small cell lung cancer

Daiki Ogawara, Minoru Fukuda, Yoichi Nakamura, et al

Cancer Management and Research 2010, 2:191-195

Published Date: 11 August 2010

Cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials

Didier Dequanter, Mohammad Shahla, Pascal Paulus, et al

Cancer Management and Research 2010, 2:165-168

Published Date: 28 June 2010

Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer

Noemí Reguart, Andrés Felipe Cardona, Rafael Rosell

Cancer Management and Research 2010, 2:143-156

Published Date: 1 June 2010

Management of metastatic renal cell carcinoma in patients with poor prognosis

Andrea Bullock, David F McDermott, Michael B Atkins

Cancer Management and Research 2010, 2:123-132

Published Date: 24 May 2010

Global cancer research initiative

Richard R Love

Cancer Management and Research 2010, 2:105-109

Published Date: 3 May 2010

Role of bevacizumab therapy in the management of glioblastoma

Scott J Peak, Victor A Levin

Cancer Management and Research 2010, 2:97-104

Published Date: 22 April 2010

Rituximab for the treatment of patients with chronic lymphocytic leukemia

M Gentile, E Vigna, C Mazzone, et al

Cancer Management and Research 2010, 2:71-81

Published Date: 11 March 2010

Everolimus – a new approach in the treatment of renal cell carcinoma

G Anandappa, AE Hollingdale, TG Eisen

Cancer Management and Research 2010, 2:61-70

Published Date: 9 March 2010

Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma

Frederick Lansigan, Diane M Stearns, Francine Foss

Cancer Management and Research 2010, 2:53-59

Published Date: 5 February 2010

Evaluation of degarelix in the management of prostate cancer

Hendrik Van Poppel

Cancer Management and Research 2010, 2:39-52

Published Date: 25 January 2010

Optimal management of cancer anorexia–cachexia syndrome

Josep M Argilés, Mireia Olivan, Sílvia Busquets, et al

Cancer Management and Research 2010, 2:27-38

Published Date: 22 January 2010

Role of lapatinib in the first-line treatment of patients with metastatic breast cancer

Catherine Oakman, Marta Pestrin, Elena Zafarana, et al

Cancer Management and Research 2010, 2:13-25

Published Date: 7 January 2010